Abstract

Introduction: There is growing evidence that high sensitivity troponin I (hs-cTnI) and high sensitivity troponin T (hs-cTnT) are associated with distinct clinical characteristics and perform differently for cardiovascular risk stratification. The comparative associations of hs-cTnI and hs-cTnT with microvascular complications, such as peripheral neuropathy (PN), have not been quantified. Methods: We conducted a cross-sectional analysis of 2,974 black and white participants in the ARIC study who underwent monofilament PN testing at visit 6 (2016-2017, age 71-94 years). Hs-cTnI and hs-cTnT were measured in serum and categorized according to population tertiles. We used logistic regression to assess the associations of hs-cTnI and hs-cTnT with PN among adults with and without diabetes after adjusting for traditional risk factors. Results: Overall, 38% of participants had evidence of PN. Median hs-cTnI and hs-cTnT levels were 3.3ng/L (IQR 2.2-5.2) and 11.0ng/L (8.0-16.0) for participants with PN and 2.6ng/L (1.8-4.0) and 8.0ng/L (6.0-12.0) for participants without PN, respectively. Only hs-cTnT was significantly associated with PN after adjusting for traditional risk factors ( Figure, panel A ) and after mutually adjusting for both troponin measurements ( Figure, panel B ). The association of hs-cTnT with PN was similar for adults with and without diabetes (P=0.62 for interaction). Conclusions: PN was common among older adults with and without diabetes. Hs-cTnI and hs-cTnT had distinct associations with PN, with a more robust association for hs-cTnT. These findings add to the growing body of knowledge regarding differences in the use of high sensitivity troponin assays for monitoring risk in the general population.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call